[서울신문] Ants having fun as a contest for’Small Combat’, look at real IPOs in the second half of the year

Public offering stock subscription system with improved accessibility

Secured 1 share of SK Bio for 320,000 won margin
Small capital investment is also possible in an equal distribution method
Subscription yield is better than public offering funds
Large fish-class lines such as Kakao’s 3 brothers are waiting

In the process of listing SK Biosciences, a pharmaceutical company, interest in the subscription to public offerings grew as the success stories of ants who made a high return by investing only a small amount of investment were shared.

Although on the 22nd, the third day of listing, the market was finished at 144,000 won, which dropped more than 13%, but compared to the public offering price (65,000 won), the price is still more than doubled. Thanks to the public offering stock subscription system that has changed since this year, the opportunity to invest in public offering stocks, which seemed to be the exclusive property of asset prices, has also been opened to ants (individual investors).

According to the financial investment industry on the 22nd, public offering funds also gained a valuation margin of 0.3~7% depending on the management method due to the effect of listing on SK Bioscience. The success of this company on the first day of listing (recording the upper limit after the initial price is formed at twice the public offering price) is the result reflected in the fund base price the next day. The recently launched Hyundai M Multi-Hedge KOSDAQ Venture Securities Investment Trust No. 1 (7.46%) achieved a high performance in the 7% range. 1.65%), BNK Public Stock Plus 10 Securities Investment Trust No. 1 (1.17%), etc. raised 1% valuation gains.

A public offering fund is a fund that collects investments from customers and buys major public offerings. Basically, the more margins you place, the more shares you receive. For this reason, individual investors with weak funding power were better to invest indirectly through the fund than to subscribe directly.

However, in the subscription of SK Bioscience, individuals who directly invested even a small amount made higher returns than those who invested through the fund. The valuation gain per share that small subscribers earned on the first day of listing was 104,000 won, and if they received 6 weeks, they could earn a total valuation gain of 624,000 won on the first day. The total margin-to-margin rate of return reached 32%. This is thanks to the changed public offering stock subscription method since this year. Until last year, in order to receive one share of popular public offering stocks, at least tens of millions of won had to be put in as margin, but from this year, half of the public offering stocks distributed to individuals were distributed equally.

For this reason, individual investors who directly subscribed for the minimum subscription quantity of 10 shares were able to receive at least 1 share (excluding some organizers) even if they entrusted only 325,000 won of margin. In addition, SK Bioscience co-hosts six securities companies, respectively, so they paid a total margin of 1.95 million won and received more than six weeks.

Although the subscription to public offerings by real companies is small, attention is paid to the remainder of this year’s IPO schedule as it attracts attention as a reliable investment destination. In the market, Kakao’s three brothers (Kakao Pay, Kakao Bank, Kakao Entertainment), as well as Krafton, Yanolja, and LG Energy Solutions are paying attention.

An official from NH Investment & Securities said, “Because the government is pursuing a plan to prohibit multiple subscriptions for each host company, there is no guarantee that the direct subscription method will continue to yield better returns than investing in public offering funds. “You have to carefully weigh the set size and the rate of return over the years,” he said.

Reporter Yoo Dae-geun [email protected]